However, a recent detailed analysis of patient-derived prostate cancer organoids reported that PTEN loss did not cause selective sensitivity to PI3K isoform inhibitors and that changes in isoform dependency might take place [88]. This evidence concerns the gene PIK3CD and prostate carcinoma.